Cargando…
Clinical Value and Underlying Mechanisms of Upregulated LINC00485 in Hepatocellular Carcinoma
AIMS: This study aimed to reveal the functional role of LINC00485 in hepatocellular carcinoma (HCC). MATERIALS & METHODS: 210 serum samples from Zhongnan Hospital of Wuhan University were employed to evaluate clinical value of LINC00485. Bioinformatics analysis was adopted to explore its potenti...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288074/ https://www.ncbi.nlm.nih.gov/pubmed/34290977 http://dx.doi.org/10.3389/fonc.2021.654424 |
_version_ | 1783724029915430912 |
---|---|
author | Zhu, Xinyu Feng, Yanlin He, Dingdong Wang, Zi Huang, Fangfang Tu, Jiancheng |
author_facet | Zhu, Xinyu Feng, Yanlin He, Dingdong Wang, Zi Huang, Fangfang Tu, Jiancheng |
author_sort | Zhu, Xinyu |
collection | PubMed |
description | AIMS: This study aimed to reveal the functional role of LINC00485 in hepatocellular carcinoma (HCC). MATERIALS & METHODS: 210 serum samples from Zhongnan Hospital of Wuhan University were employed to evaluate clinical value of LINC00485. Bioinformatics analysis was adopted to explore its potential mechanisms. RESULTS: LINC00485 was confirmed to be upregulated in HCC tissues and serum samples. Survival analysis and receiver operating characteristic curve revealed its prognostic and diagnostic roles. The combination of serum LINC00485 with AFP can remarkably improve diagnostic ability of HCC. Exploration of the underlying mechanism demonstrated that LINC00485 might exert pro-oncogenic activity by LINC00485—three miRNAs—four mRNAs network. CONCLUSIONS: Our study unveiled that upregulated LINC00485 could act as a potential diagnostic and prognostic biomarker and provide a novel insight into the molecular mechanisms of LINC00485 in HCC pathogenesis. |
format | Online Article Text |
id | pubmed-8288074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82880742021-07-20 Clinical Value and Underlying Mechanisms of Upregulated LINC00485 in Hepatocellular Carcinoma Zhu, Xinyu Feng, Yanlin He, Dingdong Wang, Zi Huang, Fangfang Tu, Jiancheng Front Oncol Oncology AIMS: This study aimed to reveal the functional role of LINC00485 in hepatocellular carcinoma (HCC). MATERIALS & METHODS: 210 serum samples from Zhongnan Hospital of Wuhan University were employed to evaluate clinical value of LINC00485. Bioinformatics analysis was adopted to explore its potential mechanisms. RESULTS: LINC00485 was confirmed to be upregulated in HCC tissues and serum samples. Survival analysis and receiver operating characteristic curve revealed its prognostic and diagnostic roles. The combination of serum LINC00485 with AFP can remarkably improve diagnostic ability of HCC. Exploration of the underlying mechanism demonstrated that LINC00485 might exert pro-oncogenic activity by LINC00485—three miRNAs—four mRNAs network. CONCLUSIONS: Our study unveiled that upregulated LINC00485 could act as a potential diagnostic and prognostic biomarker and provide a novel insight into the molecular mechanisms of LINC00485 in HCC pathogenesis. Frontiers Media S.A. 2021-07-05 /pmc/articles/PMC8288074/ /pubmed/34290977 http://dx.doi.org/10.3389/fonc.2021.654424 Text en Copyright © 2021 Zhu, Feng, He, Wang, Huang and Tu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhu, Xinyu Feng, Yanlin He, Dingdong Wang, Zi Huang, Fangfang Tu, Jiancheng Clinical Value and Underlying Mechanisms of Upregulated LINC00485 in Hepatocellular Carcinoma |
title | Clinical Value and Underlying Mechanisms of Upregulated LINC00485 in Hepatocellular Carcinoma |
title_full | Clinical Value and Underlying Mechanisms of Upregulated LINC00485 in Hepatocellular Carcinoma |
title_fullStr | Clinical Value and Underlying Mechanisms of Upregulated LINC00485 in Hepatocellular Carcinoma |
title_full_unstemmed | Clinical Value and Underlying Mechanisms of Upregulated LINC00485 in Hepatocellular Carcinoma |
title_short | Clinical Value and Underlying Mechanisms of Upregulated LINC00485 in Hepatocellular Carcinoma |
title_sort | clinical value and underlying mechanisms of upregulated linc00485 in hepatocellular carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288074/ https://www.ncbi.nlm.nih.gov/pubmed/34290977 http://dx.doi.org/10.3389/fonc.2021.654424 |
work_keys_str_mv | AT zhuxinyu clinicalvalueandunderlyingmechanismsofupregulatedlinc00485inhepatocellularcarcinoma AT fengyanlin clinicalvalueandunderlyingmechanismsofupregulatedlinc00485inhepatocellularcarcinoma AT hedingdong clinicalvalueandunderlyingmechanismsofupregulatedlinc00485inhepatocellularcarcinoma AT wangzi clinicalvalueandunderlyingmechanismsofupregulatedlinc00485inhepatocellularcarcinoma AT huangfangfang clinicalvalueandunderlyingmechanismsofupregulatedlinc00485inhepatocellularcarcinoma AT tujiancheng clinicalvalueandunderlyingmechanismsofupregulatedlinc00485inhepatocellularcarcinoma |